Industry calls for UK to attract top life sciences talent

30 October 2025

If the UK is to become Europe’s leading life sciences economy by 2030, it must sharpen its global appeal and do more to attract and keep world-class talent.

So says the Association of the British Pharmaceutical Industry (ABPI) in a message to the UK government. The trade group has stressed that the nation’s life sciences sector supports more than 300,000 high-skilled jobs across the country and includes the pharmaceutical industry, which alone accounted for £8.7 billion ($11.5 billion) in research and development (R&D) investment in 2023.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight



More Features in Pharmaceutical